(Q74512972)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Analysis of HLA class I expression in different metastases from two melanoma patients undergoing peptide immunotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

R Mendez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Serrano

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

E Jäger

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

I Maleno

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F Ruiz-Cabello

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

A Knuth

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

F Garrido

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 June 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

508-519

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

Natural history of HLA expression during tumour development.

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Differences in the antigens recognized by cytolytic T cells on two successive metastases of a melanoma patient are consistent with immune selection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

beta2-Microglobulin mutations, HLA class I antigen loss, and tumor progression in melanoma.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Mutations of the beta2-microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

A simple salting out procedure for extracting DNA from human nucleated cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Immunophenotyping of melanomas for tyrosinase: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Serological analysis of Melan-A(MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Loss of an HLA haplotype in pancreas cancer tissue and its corresponding tumor derived cell line

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Molecular strategies to define HLA haplotype loss in microdissected tumor cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Dinucleotide repeat polymorphisms at the D11S419 and CD3D loci

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

The 1993-94 Généthon human genetic linkage map

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Characterization of a gastric tumor cell line defective in MHC class I inducibility by both alpha- and gamma-interferon

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic-T-cell responses: evidence for immunoselection of antigen-loss variants in vivo

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Impediments to successful immunotherapy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Suboptimal activation of melanoma infiltrating lymphocytes (TIL) due to low avidity of TCR/MHC-tumor peptide interactions

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

[Disseminated tumor cells: diagnosis, prognostic relevance, phenotyping and therapeutic strategies]

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-0039.2001.057006508.X

7 January 2021

10.1034/J.1399-0039.2001.057006508.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11556981%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference